Ventas (NYSE:VTR) Price Target Raised to $100.00 at Citigroup

Ventas (NYSE:VTR) had its price target upped by investment analysts at Citigroup from $96.00 to $100.00 in a report released on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the real estate investment trust’s stock. Citigroup’s price target would suggest a potential upside of 13.50% from the stock’s previous close.

Several other equities analysts have also issued reports on the company. Argus set a $88.00 price target on Ventas in a research note on Tuesday, February 10th. Mizuho upped their price target on Ventas from $87.00 to $94.00 and gave the company an “outperform” rating in a research note on Wednesday, March 4th. Evercore reaffirmed an “outperform” rating and set a $95.00 price target on shares of Ventas in a research note on Wednesday. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $93.00 price target on shares of Ventas in a research note on Monday, February 9th. Finally, UBS Group reaffirmed a “neutral” rating and set a $85.00 price target on shares of Ventas in a research note on Monday, February 9th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Ventas presently has an average rating of “Moderate Buy” and a consensus target price of $91.73.

Ventas Price Performance

Shares of VTR stock traded up $0.25 during trading hours on Friday, hitting $88.11. 2,895,238 shares of the company’s stock were exchanged, compared to its average volume of 3,360,939. The stock’s 50-day moving average is $84.79 and its 200-day moving average is $80.03. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.25 and a quick ratio of 0.67. The stock has a market cap of $41.89 billion, a price-to-earnings ratio of 160.20, a price-to-earnings-growth ratio of 2.15 and a beta of 0.75. Ventas has a 52 week low of $61.76 and a 52 week high of $88.41.

Ventas (NYSE:VTR) last issued its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a net margin of 4.25% and a return on equity of 2.09%. The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the company earned $0.84 EPS. The company’s revenue was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, research analysts forecast that Ventas will post 3.85 EPS for the current year.

Insider Activity

In other Ventas news, CEO Debra A. Cafaro sold 10,322 shares of the stock in a transaction dated Monday, February 2nd. The stock was sold at an average price of $77.66, for a total value of $801,606.52. Following the transaction, the chief executive officer owned 1,114,034 shares of the company’s stock, valued at approximately $86,515,880.44. This represents a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Carey S. Roberts sold 35,532 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total value of $3,020,220.00. Following the completion of the transaction, the executive vice president directly owned 72,755 shares in the company, valued at $6,184,175. The trade was a 32.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.53% of the company’s stock.

Hedge Funds Weigh In On Ventas

Several hedge funds have recently added to or reduced their stakes in the stock. Simplicity Wealth LLC lifted its stake in Ventas by 15.2% in the first quarter. Simplicity Wealth LLC now owns 4,508 shares of the real estate investment trust’s stock valued at $369,000 after buying an additional 596 shares during the period. Candriam S.C.A. raised its position in shares of Ventas by 163.2% during the first quarter. Candriam S.C.A. now owns 133,228 shares of the real estate investment trust’s stock worth $10,895,000 after purchasing an additional 82,606 shares during the period. Sequoia Financial Advisors LLC raised its position in shares of Ventas by 1.2% during the first quarter. Sequoia Financial Advisors LLC now owns 12,894 shares of the real estate investment trust’s stock worth $1,054,000 after purchasing an additional 148 shares during the period. Hsbc Holdings PLC raised its position in shares of Ventas by 2.9% during the first quarter. Hsbc Holdings PLC now owns 1,993,819 shares of the real estate investment trust’s stock worth $163,101,000 after purchasing an additional 55,339 shares during the period. Finally, Ibex Wealth Advisors acquired a new stake in shares of Ventas during the first quarter worth about $423,000. Institutional investors and hedge funds own 94.18% of the company’s stock.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.